Week #6 Rockville/Bethesda/Chevy Chase Gazette Ad Campaign

Read/Download Richard Ripp Rockville Gazette Ad richardrippgazettecolor.pdf

Please visit the FDA Protest 5/30/08 page and help us spread the word. There is much that everyone can do to help raise awareness. Thanks. CareToLive

(click to enlarge)

Popularity: 37%

May 6 at 8AM
Keynote speaker: Janet Woodcock, MD, Deputy Commissioner, FDA, Director, Center for Drug Evaluation and Research (CDER)

http://www.temple.edu/pharmacy_qara/08agenda.htm

VISIT OUR RALLY PAGE FOR MAY 30, 2008 NATIONWIDE PROSTATE CANCER DEMONSTRATION DETAILS http://caretolive.com/rally/

We are also looking for a demonstration coordinator to organize outside of Michael Milken’s The Prostate Cancer Foundation in Santa Monica. They have sadly been silent regarding the Provenge delay and need a wake up call.

HOPE TO SEE YOU AT THE PROTEST!

Popularity: 35%

4/16/08 The Care To Live Awareness Campaign in the Rockville Gazette, continues to confront the FDA to address our Petition for the FDA to Reconsider their decision to delay Provenge in what was an unprecedented action by them to delay a treatment in an end stage disease where no other options exist, despite the fact that Provenge was voted 17-0 Safe and 13-4 Efficacious by an FDA Advisory Panel.

Please email, print and fax our ads to help increase awareness of the Provenge Debacle so we may reverse this tragedy. It is over a year since the Advisory Panel was convened. 30,000 American men die each year of prostate cancer. 1 in 6 men will get prostate cancer in their lifetimes. We need better, safer treatments NOW! The FDA needs to address the needs of the men with end stage prostate cancer, and allow them access to the immunotherapy Provenge IMMEDIATELY!

Stephen H. Study Died without ever receiving Provenge. Shame on those individuals at the FDA responsible for this genocide. They are so concerned about selling men drugs to enhance their sex lives, and have completely ignored the real needs of our men, the approval of drugs that have prolonged survival. Some men who received Provenge in trials are alive 6 years longer.

Week #3 Color Ad caretoliverockvillegazettesstudyad3a.pdf

Week #3 Black & White Ad caretoliverockvillegazettesstudyad3abw.pdf

Popularity: 38%

WEEK #2

Week 2 Ad Color caretoliverockvillegazette2ad.pdf

Week 2 Ad Black & White caretoliverockvillegazette2adbw.pdf

Popularity: 25%

We are hot on the trail of the miscreants that derailed Provenge, a safe and effective immunotherapy for prostate cancer, condemning 30,000 American men to death without hope, in order to reap windfall profits.

Ed Silverman of Pharmalot reports on the shenanigans. (click link)

They may have taken down the links but we have the Proquest Investments 2007 Scientific Advisory Committee on our CareToLive research page showing the connections to Howard Scher and Milken’s Prostate Cancer Foundation that claims they want faster cures, yet remained mum on the Provenge Debacle. 3 Congressment are now calling for a Congressional hearing.

See our prior blog on Michael Milken’s Prostate Cancer Foundation and The Proquest Investment Fund / Howard Scher /FDA Unholy Alliance.(click link)

CareToLive is asking the public to help get to the bottom of the Provenge debacle by joining Congressmen Mike Michaud of Maine, Dan Burton of Indiana, and Tim Ryan of Ohio, who are calling for a congressional hearing into what happened. Contact your elected officials to ask for a congressional hearing, visiting the CareToLive website, dig our blogs, and join in the battle.

30,000 American men will die each year (not to mention the rest of the world) without this safe and effective immunotherapy. 1 in 6 men will get prostate cancer int heir lifetime. The FDA’s delay of Provenge was unprecedented in a terminal disease with an overwhelmingly positive panel that showed survival advantages, where no other options exist. Only one treatment for prostate cancer has been approved in 42 years. Send a clear message to Congress, the dysfunctional FDA, Wall Street, and the Chemo Cartel that we want this nontoxic immunotherapy approved NOW! More than 10 years of trials have shown it increases survival. Some men are alive as long as 6 years.

CONGRESSIONAL LETTER ASKING FOR A HEARING  PDF (click here) Please fax this letter to your own congressional representatives and ask them to join this action. TIA
Continue Reading Proquest Tries to Cover Its Tracks over Scher Provenge Debacle »

Popularity: 35%

While Michael Milken and the Prostate Cancer Foundation are whooping it up at the ballgame, some men are sneaking off to have their testicles removed in hopes that it will stop their PSA from rising, and their lives from ending prematurely from late stage prostate cancer. 1 in 6 men will be diagnosed with prostate cancer in their lifetimes. Over 30,000 American men will die from prostate cancer this year. Only 1 very toxic drug has been approved for late stage pc in over 42 years.

Along came Dendreon’s Provenge, an Immunotherapy voted overwhelmingly safe and effective by the FDA’s panel of experts convened to review Provenge. Was there foul play afoot when the FDA decided to delay approval. Perhaps if our men put some extra pine tar on their bats, we could get some coverage of this story. You would think that the deaths of 15,000 men since the delay would be enough.

Note the Picture on the bottom — David Solit, Tommy Lasorda, Dr. Howard Soule, Dr. Howard Scher and Mike Milken join together in support of the PCF’s Home Run Challenge at the New York Mets vs. Anaheim Angels game on June 10th, 2005 (click link)

Why hasn’t Michael Milken and his Prostate Cancer Foundation stepped up to the plate and publicly voiced his disappointment and disapproval of the decision by the FDA to delay Provenge? Is Milken financially conflicted? The whole thing is permeating a stench in the world of financially conflicted advocacy groups. Continue Reading Michael Milken and the Prostate Cancer Foundation’s Foul Balls »

Popularity: 95%